![Gregg Lapointe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregg Lapointe
Président chez
RIGEL PHARMACEUTICALS, INC.
Fortune : 556 471 $ au 31/05/2026
Profil
Gregg Anthony Lapointe is the founder of Cerium Pharmaceuticals, Inc. Current positions include Chairman at Rigel Pharmaceuticals, Inc. since 2022, Chairman at Horizon Pharmaceutical LLC since 2015, Independent Director at Soligenix, Inc. since 2009, Director at S1 BioPharma, Inc. since 2014, Director at Cytori Therapeutics, Inc., and Member-Corporate Council at Child Neurology Foundation.
Former roles include Chief Executive Officer at Essetifin SpA in 2012, Chief Executive Officer at Leadiant Biosciences, Inc. from 2008 to 2012, Independent Director at SciClone Pharmaceuticals LLC from 2011 to 2016, Director at Questcor Pharmaceuticals, Inc. from 2005 to 2007, Independent Director at ImmunoCellular Therapeutics Ltd. from 2015 to 2017, Independent Director at Astria Therapeutics, Inc. from 2019 to 2026, Independent Director at Plus Therapeutics, Inc. from 2017 to 2020, Director at Raptor Pharmaceuticals Corp.
from 2014 to 2016, Director at Pharmaceutical Research & Manufacturers of America from 2009 to 2012, Director at Ajinomoto Cambrooke, Inc., Director at The Signature Group, Inc. (Virginia), Member-Corporate Council at Kidney Care Partners, Vice President-Operations & Controller at AstenJohnson, Inc. from 1996 to 2001, Trustee at Keck Graduate Institute of Applied Life Sciences, and Member-Corporate Council at The National Organization for Rare Disorders, Inc. Education includes an MBA from Duke University and undergraduate studies at Concordia University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/05/2026 | 18 250 ( 0,1 % ) | 556 443 $ | 31/05/2026 | |
| 20/06/2025 | 31 ( 0 % ) | 28 $ | 31/05/2026 |
Postes actifs de Gregg Lapointe
| Sociétés | Poste | Début |
|---|---|---|
| SOLIGENIX, INC. | Directeur/Membre du Conseil | 01/03/2009 |
| RAPTOR PHARMACEUTICAL CORP | Président | 01/08/2015 |
| RIGEL PHARMACEUTICALS, INC. | Président | 01/05/2022 |
S1 BioPharma, Inc.
 S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment of sexual dysfunction | Directeur/Membre du Conseil | 01/08/2014 |
Cerium Pharmaceuticals, Inc.
 Cerium Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapies for patients with kidney diseases | Directeur Général | 01/04/2012 |
Child Neurology Foundation | Corporate Officer/Principal | - |
Cytori Therapeutics, Inc.
 Cytori Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment and devices for cell therapy | Directeur/Membre du Conseil | - |
Anciens postes connus de Gregg Lapointe
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 23/01/2026 |
| PLUS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 31/01/2020 |
| ░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Gregg Lapointe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Soligenix, Inc.
 Soligenix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes biodefense vaccines and oral therapeutic products | Health Technology |
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer and infectious diseases | Health Technology |
Essetifin SpA
 Essetifin SpA Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in pharmaceutical preparations | Health Technology |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets and sells prescription drugs | Health Technology |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Concordia University
 Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for rare diseases | Health Technology |
AstenJohnson, Inc.
 AstenJohnson, Inc. Industrial MachineryProducer Manufacturing Manufactures paper machine clothing, specialty fabrics, filaments and drainage equipment | Producer Manufacturing |
Keck Graduate Institute of Applied Life Sciences
 Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
The National Organization for Rare Disorders, Inc.
 The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services | Health Services |
Child Neurology Foundation | |
Kidney Care Partners
 Kidney Care Partners Medical/Nursing ServicesHealth Services Operates as nephrologists | Health Services |
Ajinomoto Cambrooke, Inc.
 Ajinomoto Cambrooke, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets oral nutrition powders and shakes | Health Technology |
The Signature Group, Inc. (Virginia)
 The Signature Group, Inc. (Virginia) Miscellaneous Commercial ServicesCommercial Services Provides information technology consulting and management services | Commercial Services |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Cerium Pharmaceuticals, Inc.
Cerium Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapies for patients with kidney diseases | Health Technology |
S1 BioPharma, Inc.
S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment of sexual dysfunction | Health Technology |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment and devices for cell therapy | Health Technology |
